MIRABEGRON

• tagApproval8 co-mentions · 4 sources
• drugmirabegron ER4 co-mentions · 4 sources
• tagSmall Molecule4 co-mentions · 4 sources
• drugmirabegron SR4 co-mentions · 4 sources
• companyLupin Ltd2 co-mentions · 2 sources

Trials studying MIRABEGRON

• phase3A Study to Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivityactive not recruitingn=7
• phase4Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)completedn=888
• phase3A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.completedn=1,887
• phase3A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladdercompletedn=2,030
• phase3Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladdercompletedn=2,336
• phase3A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladdercompletedn=2,149
• phase3Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladdercompletedn=2,792
• phase4A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladdercompletedn=249